Literature DB >> 1647201

Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form.

A I Marcy1, L L Eiberger, R Harrison, H K Chan, N I Hutchinson, W K Hagmann, P M Cameron, D A Boulton, J D Hermes.   

Abstract

Stromelysin-1 is a member of a tissue metalloproteinase family whose members are all capable of degrading extracellular matrix components. A truncated form of human fibroblast prostromelysin 1 lacking the C-terminal, hemopexin-like domain has been expressed in Escherichia coli and purified to homogeneity. Treatment of this short form of prostromelysin with (aminophenyl)mercuric acetate resulted in activation and loss of the propeptide in a manner identical with the wild-type, full-length protein. Kinetic comparisons using Nle11-substance P as a substrate showed that the wild-type stromelysin and the truncated form of the enzyme had similar kcat and Km values. Likewise, both enzymes displayed similar Ki values for a hydroxamate-containing peptide inhibitor. Taken together, these results indicate that the C-terminal portion of stromelysin is not required for proper folding of the catalytic domain, maintenance of the enzyme in a latent form, activation with an organomercurial, cleavage of a peptide substrate, or interaction with an inhibitor. Moreover, the active short form of stromelysin displayed a reduction in the C-terminal heterogeneity, a characteristic degradation of the full-length stromelysin, and thereby provides a more suitable protein for future structural studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647201     DOI: 10.1021/bi00240a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.

Authors:  B C Finzel; E T Baldwin; G L Bryant; G F Hess; J W Wilks; C M Trepod; J E Mott; V P Marshall; G L Petzold; R A Poorman; T J O'Sullivan; H J Schostarez; M A Mitchell
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

2.  Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.

Authors:  Jyotica Batra; Jessica Robinson; Alexei S Soares; Alan P Fields; Derek C Radisky; Evette S Radisky
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

3.  Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography.

Authors:  P R Gooley; J F O'Connell; A I Marcy; G C Cuca; M G Axel; C G Caldwell; W K Hagmann; J W Becker
Journal:  J Biomol NMR       Date:  1996-01       Impact factor: 2.835

4.  X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin.

Authors:  P Dunten; U Kammlott; R Crowther; W Levin; L H Foley; P Wang; R Palermo
Journal:  Protein Sci       Date:  2001-05       Impact factor: 6.725

5.  Stromelysin expression in IL-1 beta stimulated bovine articular cartilage explants.

Authors:  S Wertheimer; S Katz; K Rowan; A Lugo; W Levin; A C Hanglow
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

6.  Bioactive conformation of stromelysin inhibitors determined by transferred nuclear Overhauser effects.

Authors:  N C Gonnella; R Bohacek; X Zhang; I Kolossváry; C G Paris; R Melton; C Winter; S I Hu; V Ganu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

7.  The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.

Authors:  S Gilbertson-Beadling; E A Powers; M Stamp-Cole; P S Scott; T L Wallace; J Copeland; G Petzold; M Mitchell; S Ledbetter; R Poorman
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Fragmentation of human polymorphonuclear-leucocyte collagenase.

Authors:  V Knäuper; A Osthues; Y A DeClerck; K E Langley; J Bläser; H Tschesche
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

9.  A single step purification for autolytic zinc proteinases.

Authors:  Erin M Wilfong; Ursala Locklear; Eric J Toone
Journal:  Bioorg Med Chem Lett       Date:  2009-11-05       Impact factor: 2.823

10.  Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.

Authors:  Joen R Sheu; Tsorng H Fong; Cheng M Liu; Ming Y Shen; Ta L Chen; Yi Chang; Meng S Lu; George Hsiao
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.